Fonkomustin 100 mg

Fonkomustin 100 mg

GENERIC NAME:

Bendamustine HCl Lyophilized Powder for Injection

INDICATIONS:

First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate

Indolent non-Hodgkin’s lymphomas as monotherapy in patients who have progressed during or within 6 months following treatment with rituximab or a rituximab-containing regimen

Front-line treatment of multiple myeloma (Durie-Salmon stage II with progress or stage III) in combination with prednisone, in patients older than 65 years not eligible for autologous stem cell transplantation and with clinical neuropathy at diagnosis precluding thalidomide or bortezomib-containing treatment

STRENGTH:

100 mg per vial

PACK SIZE:

Box of 1 vial x 100 mg

DOSAGE FORM:

Lyophilized powder for injection (intravenous infusion after reconstitution)

CATEGORIES:

Pharmaceuticals

THERAPEUTIC CLASS:

Alkylating Antineoplastic Agent – Nitrogen Mustard Analogue (ATC: L01AA09)

Products Information